header

langue fr langage en

Les présentations du congrès bénéficiant d'une autorisation de diffusion sont consultables sur le programme ci-après en cliquant sur le pictogramme en forme d'écran.


HEART FEALURE

09.00 - 10.30

Chairmen

S. VARNOUS, R. ISNARD, G. LEBRETON

Update on heart failure drugs - including Vericiguat

E. VERMES

Surgical treatment of atrial fi brillation in heart failure

M. LA MEIR

Advanced heart failure monitoring with cardiomems

P. DEGROOTE

New guidelines on the management of the heart transplanted patient

G. COUTANCE

Heart transplantation for patients over 70 years old

R. DORENT


HEART TRANSPLANTATION

11.00 - 12.50

Chairmen

P. LEPRINCE, S. VARNOUS, G. LEBRETON

Update from the Biomedecine agency. Thoracic organs transplantation in 2021

R. DORENT

Clinical case. Acute cardiac graft dysfunction: next step after normal biopsy and coronary angiography?

L. LECUYER

Skin cancers in heart transplanted patients: really a problem in 2022?

S. BARETE

Top Chef in heart transplant

E. EPAILLY

Lung transplant allocation - Today and tomorrow, here and elsewhere

J. MESSIKA

Impact of changing cardiac graft allocation policy on the profi le of heart transplant candidates and transplanted patients. La Pitié experience

E. DESIRE

Impact of new heart allocation policy in US

W. PARKER


OPENING CEREMONY

12.50 - 13.00

Chairmen

M. TSIMARATOS, P. MAISANI

12.50 - 13.00

OPENING CEREMONY
M. TSIMARATOS, P. MAISANI

TRANSPLANTATION AND PREGNANCY

16:00 - 18:15

Chairmen

S. VARNOUS, G. COUTANCE, E. EPAILLY

Summary of ISHLT guidelines

M. KITTLESON

Lung Transplantation

C. PICARD

Christel’s register

A. HERTIG

Update inolecular biology data in heart transplantation

A. GIARRAPUTO

Impact of organ donor characteristics on predictive models for post cardiac transplantation outcome

M. LESCROART

Results of the miRRACLE study (non-invasive screening of cardiac allograft rejection by circulating microRNA assay)

G. COUTANCE


INFECTIOUS COMPLICATIONS AFTER HEART TRANSPLANTATION

09.00 - 10.30

Chairmen

G. COUTANCE, S. BOVAGNET, C. COELEMBIER

Recurrent infections in a heart transplanted patient: case report

L. LECUYER

Main issue - the nurse key role

S. JAMET

The main issues with the immunocompromised patient

Y. TAMZALI

Vaccinations before and after heart transplantation

F. HAZAN

Preventing infections in transplanted patients

M. LESCROART


UPDATE FROM THE BIOMEDECINE AGENCY

11.00 - 11.20

Chairmen

S. VARNOUS, H. AUDOUIN, P. LEPRINCE

Thoracic organs transplantation in 2021

R. DORENT


HEART FAILURE AND PREGNANCY

11.20 - 12.20

Chairmen

S. VARNOUS, H. AUDOUIN, P. LEPRINCE

Clinical case: When anticipating is associated with success

O. CAZIMAJOU, J. PERRIN

Heart failure and pregnancy: the cardiologist point of view

L. LEGRAND

Heart failure and pregnancy: the obstetrician point of view

J. NIZARD

Pregnancy and heart transplantation: clinical experience

E. DESIRE


OPENING CEREMONY

12.20 - 12.30

Chairmen

F. ROGER, C. LE CORRE

12.20 - 12.30

OPENING CEREMONY
F. ROGER, C. LE CORRE

SHORT AND LONG TERM MECHANICAL CIRCULATORY SUPPORTS

13.30 - 15.15

Chairmen

G. LEBRETON, I. NDOUR, N. DJAVIDI

HM6 et assistance biventriculaire / coeur artificiel total

A. LABOURE, C. DE ARAUJO, G. LEBRETON

Impella in operating room

E. BERG, G. LEBRETON

Impella in intensive care

J. GICQUEL, A. PEUCH

Equipe dédiée choc cardiogénique : Impact pronostic

C. SORBIER, A. OUATTARA

Perfusion de greffons cardiaques Xvivo

P. LE GLOAHEC, T. ROY, G. LEBRETON


THINGS ARE MOVING IN HEART TRANSPLANTATION

15.45 - 18.00

Chairmen

S. VARNOUS, H. AUDOUIN, G. COUTANCE

Fewer and fewer contra-indications?

E. DESIRE

Towards an individualized follow-up?

G. COUTANCE

First update of the remote monitoring of heart transplant patients at La Pitié

E. COCHAT, Y. BLACODON

Curative treatments of COVID in heart transplant patients: organization, management, indications

F. HAZAN, L. GASPARD

From France to the United States via Mexico. My story as a heart transplanted patient

M. Guillaume SIMON

La Pitié association of transplanted patients

J. CAMUS

Transforme update

C. AMREIN

Update on cardiac Xenotransplantation

P. LEPRINCE


TEMPORARY SUPPORT

08.30 - 10.30

Chairmen

G. LEBRETON, A. COMBES, A. BOUGLÉ

Anchor trial and other randomized trials: progress report

A. COMBES

ECMO VA and Covid

G. HEKIMIAN

ECMO in pulmonary embolism

O. SANCHEZ

Replacement of ECMO membranes: indications and results

T. GENTY

Predicting the potential for recovery upon implementation of temporary assistance?

A. OUATTARA

ECI-BLAD study

A . QUESSARD

Use of Cytosorb during cardiac transplantation

E. NEMETH

Impella and VSD

C.-H. DAVID


LONG TERM ASSISTANCE

11.00 - 13.00

Chairmen

P. LEPRINCE, G. COUTANCE, M. KINDO

AMBUVAD study update

G. BAUDRY

HMIII and outcome heterogeneity in Momentum trial

N. URIEL

Post LVAD transplantation: benefit or risk?

M. DUMONT

HM3 in smaller patients

N. D’OSTREVY

Biventricular HM3: Australian experience

D. McGIFFIN

HM3: 5 year outcome (Momentum trial)

N. URIEL

Percutaneous drive-line care: review of procedures in France

M. Le BIDAN


UPDATES

14.00 - 15.00

Chairmen

G. LEBRETON, P. LEPRINCE, A. VINCENTELLI

Euromacs update

K. VEEN

Francemacs update

M. KINDO


INDUSTRIAL UPDATE

15.00 - 16.00

Chairmen

G. LEBRETON, P. LEPRINCE, A. VINCENTELLI

CorWave Update

C. RASSER

Syncardia update

S. THUAUDET

FineHeart update

L. BARANDON

Icor / Xenios update

R. TSCHAUT

Getinge update

D. MACQUART